Information on drugs and medical devices (including ones under development) appearing in this integrated report is provide as part of corporate disclosure, not for such purposes as promotion, advertising, or provision of medical advice.
Management message
Fulfilling our mission
and responsibility as
a healthcare corporate group
developing sustainably
alongside society
Group Chairman and President Mitsuo Sawai discusses the Group’s plan in the currently the harsh industry environment.

Our value creation story
Dedicated to building
a healthier future for all
With the generic drug business at the center of our operations, we will mobilize the strengths of all Group employees to continue taking on challenges to contribute to the health of as many people as possible.
- Related webpages

Value creation strategy
New growth strategy
for 2030
Strategies to maximize the Group’s corporate value.
- Japan generic
drug business - New
businesses - Message from the CFO
- Human capital strategy
(Message from the Chief Human Resources Officer) - Generic drugs market landscape
- Research & development
- Intellectual property
- Growing production capacity
- Society
- Environment
- Related webpages

Governance
Constructing
a fair, transparent
management system
We will enhance medium- to long-term corporate value by continuing to reinforce our management system and appropriately and quickly responding to changes in the external environment.
- Message from newly appointed outside directors
- Dialogue with investors and directors
- Corporate governance
- Related webpages

Dedicated to building
a healthier future for all
The Sawai Group Holdings corporate philosophy of “dedicated to building a healthier future for all” embodies our desire to contribute to the health of as many people as possible as a healthcare corporate group which develops sustainably alongside society with the generic drugs business as our core business. We will mobilize the strengths of all Group employees to pursue the challenge of meeting the expectations of all stakeholders.
Download all pages
- For printing (A4-size)
All single pages PDF (6.6MB) - For viewing (A3-size)
All facing pages PDF (5.9MB)
Download in sections
Download separate volume of Financial section
- For printing (A4-size)
All single pages PDF (1.3MB) - For viewing (A3-size)
All facing pages PDF (2.4MB)
Back issues
- Year Ended March 31, 2024
- Year Ended March 31, 2023
- Year Ended March 31, 2022
- Year Ended March 31, 2021
- Year Ended March 31, 2020
- Year Ended March 31, 2019
- Year Ended March 31, 2018
- Year Ended March 31, 2017
- Year Ended March 31, 2016
- Year Ended March 31, 2015
- Year Ended March 31, 2014
- Year Ended March 31, 2013
- Year Ended March 31, 2012
- Year Ended March 31, 2011
- Year Ended March 31, 2010
- Year Ended March 31, 2009
- Year Ended March 31, 2008
- Year Ended March 31, 2007
- Year Ended March 31, 2006
- Year Ended March 31, 2005
- Year Ended March 31, 2004
- Year Ended March 31, 2003
- Year Ended March 31, 2002
- Year Ended March 31, 2001
- Year Ended March 31, 2000